Abstract
To investigate the impact of oxandrolone on weight and lean body mass (LBM) loss after acute spinal cord injury (aSCI), this observational study compared patients who received oxandrolone with historical controls. Age, sex, injury level, admission and discharge anthropometrics, nutrition interventions, length of stay, liver function tests, sternocleidomastoid muscle area (SMA) indexed to height on admission, and follow-up computed tomography scans were collected. Twenty patients receiving oxandrolone and 20 controls were included. Oxandrolone patients lost less weight; however, no differences were observed in SMA. Oxandrolone reduced weight loss following aSCI, but larger studies are needed to assess its impact on LBM.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
